Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
06/2010
06/03/2010WO2010060941A2 Contrast agents
06/03/2010WO2010060217A1 Antibody-targeted carrier for contrast agents
06/03/2010WO2010060212A1 Single-domain antibody targeted formulations with superparamagnetic nanoparticles
06/03/2010WO2010060131A1 Liquid crystal contrast agents
06/03/2010WO2010032248A8 Multifunctional albumin conjugates
06/03/2010US20100138942 Use of the augmenter of liver regeneration protein as an apoptosis regulator
06/03/2010US20100138937 Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease
06/03/2010US20100138935 Detection of cellular stress
06/03/2010US20100136626 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
06/03/2010US20100135912 Magnetotactic bacteria mri positive contrast enhancement agent and methods of use
06/03/2010US20100135911 Spatial evolution of neural activity
06/03/2010US20100135910 Modulation of Anergy and Methods for Isolating Anergy-Modulating Compounds
06/03/2010US20100135909 Dendrimers and methods of making and using thereof
06/03/2010US20100135908 Delivery devices for modulating inflammation
06/03/2010US20100135907 Oral Drug Compliance Monitoring Using Sound Detection
06/03/2010US20100135905 Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
06/03/2010US20100135902 Papillomavirus pseudoviruses for detection and therapy of tumors
06/03/2010CA2744344A1 Antibody-targeted carrier for contrast agents
06/03/2010CA2741634A1 Models of thrombotic thrombocytopenic purpura and methods of use thereof
06/02/2010EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease
06/02/2010EP2190931A2 Optical imaging agents
06/02/2010EP2190930A2 Peptide imaging agents
06/02/2010EP2190410A2 Use of carbon nanotube for drug delivery
06/02/2010EP2061517B1 Gas-filled microvesicles with polymer-modified lipids
06/02/2010EP1438299B1 Bifunctional chelating agent for actinium
06/02/2010EP1265480B1 Chimeric animal model susceptible to human hepatitis c virus infection
06/02/2010CN101716355A Couplant for ultrasound and preparation method thereof
06/02/2010CN101716354A Ultrasonic coupling agent and application thereof
06/02/2010CN101716353A Folic acid composite used for imageology diagnosis of tumor and lymphatic metastasis tumor
06/02/2010CN101716348A Construction and application of gold-magnetic nanoparticle-based medicament carrying platform
06/02/2010CN101390746B Elastic vertical compression type pain quantitative determination instrument
06/01/2010US7727740 Methods for determining whether a chemical agent modulates enzymatic activity of an L-2-hydroxy acid oxidase
06/01/2010US7727544 treatment and/or prevention of myopia utilizing energy sorce to photopolymerize or crosslink molecules in the sclera, thereby increasing the strength of the tissue; administered via a crosslinking reagent or photopolymerizable molecule that becomes associated with the membrane
06/01/2010US7727525 Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics
06/01/2010US7727523 Graft versus host disease, induce monocytes in the blood to differentiate into dendritic cells, incubation the mixture of dendritic cells from transplant donor and recipient, administering the co-incubated dendritic cells to recipients
06/01/2010US7727513 contacting an ocular test sample with an N-phenolate betaine dye, wherein the dye undergoes a visible color change in less than about 30 minutes in the presence of bacteria at a pathogenic concentration, and thereafter detecting bacterial conjunctivitis based on the color change
06/01/2010US7727512 Nanoparticle emulsion in perfluorohydrocarbon solvent; chelating agents coupled, optionally through a spacer, to phosphoglyceride; magnetic resonance imaging; excretion of toxic paramagnetic ion
06/01/2010US7727511 Agents for imaging soluble a-beta
06/01/2010US7727155 Medium for contrast enhancement or convenience for ultrasonic, endoscopic, and other medical examinations
06/01/2010CA2370666C A tenascin-c isoform as a marker for neoplasias
06/01/2010CA2256592C Improved methods for diagnostic imaging by regulating the administration rate of a contrast agent
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
05/2010
05/27/2010WO2010058361A2 Method for the production of scaffolds for tissue engineering, comprising the use of an anchoring unit, and scaffold produced therewith
05/27/2010WO2010057944A1 Dye conjugate imaging agents
05/27/2010WO2010057317A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/27/2010WO2009151627A3 Endosome-disrupting compostions and conjugates
05/27/2010WO2009010725A3 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system
05/27/2010US20100132057 Genetically modified animal for use in evaluating harmfulness of test substance
05/27/2010US20100129293 Near Infrared Imaging Agent
05/27/2010US20100129292 Method and apparatus for noninvasive quantitative detection of fibrosis in the heart
05/27/2010US20100129291 Nicotinic desensitizers and methods of selecting, testing, and using them
05/27/2010US20100129290 Smart contrast agent and detection method for detecting transition metal ions
05/27/2010US20100129289 Compositions and methods for the detection of vulnerable plaque
05/27/2010US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same
05/27/2010DE202009017759U1 Farbstofflösung Dye solution
05/27/2010CA2743959A1 Liposomal composition for convection-enhanced delivery to the central nervous centre
05/26/2010EP2189167A1 Contrast agent containing silsesquioxane
05/26/2010EP2187986A2 Device suitable for introducing into human and/or animal bodies
05/26/2010EP2187976A2 Production of targeted mri probes by biocompatible coupling of macromolecules with charged nanoparticles
05/26/2010EP2187975A1 Methods of screening an agent in an isolated eye of a teleost
05/26/2010EP2187803A1 Multimodality agents for tumor imaging and therapy
05/26/2010CN201481562U Small animal metabolism monitoring equipment
05/26/2010CN201481561U Urine and excrement separating metabolism monitoring apparatus
05/26/2010CN201481560U Metabolism monitoring equipment
05/26/2010CN1943565B Biological degradable nano medicinal capsule with MRI tracer effect and its preparing method
05/26/2010CN1935277B Preparation for the prophylaxis of restenosis
05/26/2010CN1838978B Gastrointestinal methods and apparatus for use in treating disorders
05/26/2010CN1829735B Imaging agents
05/26/2010CN1638807B Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
05/26/2010CN101711882A Medical ultrasound coupling agent with function of fast and efficient sterilization and device thereof
05/26/2010CN101711881A Gadolinium-containing macromolecule magnetic resonance intravascular contrast medium and preparation method thereof
05/26/2010CN101711880A Preparation and application of superparamagnetic carbon nanotube contrast agent
05/26/2010CN101711879A Sterilizing medical ultrasonic coupling agent and preparation method thereof
05/26/2010CN101711872A Nano gold spherical shell material, preparation method and application in preparing medicaments for treating tumors
05/26/2010CN101711871A Silver nano-chain meshed material, preparation method thereof and application in preparing medicine for curing tumor
05/25/2010US7723474 Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies
05/25/2010US7723073 Nucleic acid sequences containing a coding sequence for a light chain of an anti-VLA-1 antibody or antigen binding fragment, and a coding sequence for a heavy chain of an anti-VLA-1 antibody or fragment; the light chain and the heavy chain form an antibody or fragment that binds VLA-1
05/25/2010US7723054 Toll-like receptor 9 modulators
05/25/2010US7722897 Patch for screening and sensitization state of a subject with respect to an allergen and use thereof
05/25/2010US7722858 Prevention and treatment of atherosclerosis by reducing carbamylation of LDL or the effects of carbamylated LDL
05/25/2010US7722856 Process for the production of a radioactive aerosol
05/25/2010CA2425703C Novel dyes for organ function monitoring
05/20/2010WO2010056590A2 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging
05/20/2010WO2010055036A1 Diagnostic and/or therapeutic agent, method for the manufacture thereof and use thereof
05/20/2010WO2010012513A3 Method for determining measured data from the stomach of a patient
05/20/2010WO2009133204A3 Vector for use in medicine
05/20/2010US20100124534 Immunotherapeutic method
05/20/2010DE102008043654A1 Diagnostisches und/oder therapeutisches Agens, Verfahren zu seiner Herstellung und Verwendung Diagnostic and / or therapeutic agent, process for its preparation and use
05/20/2010CA2742988A1 Method and formulation for reducing aggregation of a macromolecule under physiological conditions
05/19/2010EP2185272A1 Removal of silica from water soluble compounds by nanofiltration and reverse phase chromatography
05/19/2010EP0907735B9 Modulators of tissue regeneration
05/19/2010CN101708866A Superparamagnetic water-soluble manganous ferrite nano-particle and application thereof
05/19/2010CN101708165A Microspheres for active embolization
05/19/2010CN101041080B Chicken embryo elk bursa film blood vessel generating model and the analyzing method and use
05/18/2010US7718804 Quaternary nitrogen heterocyclic boronic acid-containing compounds sensitive to glucose and fructose; contact lens; radiometers; kits; ophthalmic sensors
05/18/2010US7718781 Gadolinum complex for magnetic resonance imaging contrast agent
05/18/2010US7718777 MHC-peptide complex binding ligands
05/18/2010US7718601 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors
05/18/2010CA2509715C Improved thickened beverages for dysphagia
05/14/2010WO2010054127A1 Methods and agents for stabilizing non-pathological amyloidogenic polypeptides
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 354